Te-Chun Hsia

5PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPacific Peoples epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 13, 2024
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors.

Chih-Yen Tu, Te-Chun Hsia, Ying-Chun Lin

|Mar 27, 2023
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.

Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia

|Feb 23, 2023
PW06 Triggered Fas-FADD to Induce Apoptotic Cell Death In Human Pancreatic Carcinoma MIA PaCa-2 Cells through the Activation of the Caspase-Mediated Pathway.

Yi-Ping Huang, Te-Chun Hsia, Chun-An Yeh

|Jan 15, 2021
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy.

Wen-Chien Cheng, Te-Chun Hsia, Chih-Yen Tu

|Dec 30, 2020
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment.

Wen-Chien Cheng, Biing-Ru Wu, Wei-Chih Liao

Pageof 1

Frequent Collaborators

3 joint publications

Wen-Chien Cheng

1 joint publications

Biing-Ru Wu

1 joint publications

Wei-Chun Chen

1 joint publications

Chia-Hung Chen